CD4 and neoplasm: Additionally, XCELL results demonstrated a notable decrease in CD4+ Th1 cells, a key cell for generating long-lasting anti-tumor immune responses, in the high-risk group, which may be a possible factor for the poorer prognosis (Figure 8D).